Literature DB >> 2457378

N-acetylprocainamide is a less potent inducer of T cell autoreactivity than procainamide.

B Richardson1, E Cornacchia, J Golbus, J Maybaum, J Strahler, S Hanash.   

Abstract

We have reported that an inhibitor of DNA methylation, 5-azacytidine, makes cloned, antigen-specific CD4+ T cells autoreactive, and that procainamide and hydralazine mimic this effect. Those results suggested that procainamide and hydralazine may induce autoimmunity by inhibiting DNA methylation and causing T cell autoreactivity. We report now that N-acetylprocainamide, a procainamide derivative that does not induce lupus, is also a DNA methylation inhibitor, but it is 100 times less potent than procainamide in inducing T cell autoreactivity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457378     DOI: 10.1002/art.1780310809

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  5 in total

1.  Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin.

Authors:  R W Burlingame; R L Rubin
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

2.  Metabolomics reveals the metabolic map of procainamide in humans and mice.

Authors:  Fei Li; Andrew D Patterson; Kristopher W Krausz; Bernhard Dick; Felix J Frey; Frank J Gonzalez; Jeffrey R Idle
Journal:  Biochem Pharmacol       Date:  2012-02-24       Impact factor: 5.858

3.  Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice.

Authors:  J Quddus; K J Johnson; J Gavalchin; E P Amento; C E Chrisp; R L Yung; B C Richardson
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

Review 4.  Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.

Authors:  S Y Kim; N L Benowitz
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

5.  DNA-intercalators causing rapid re-expression of methylated and silenced genes in cancer cells.

Authors:  M Zulfiquer Hossain; Megan A Healey; Calvin Lee; Weijie Poh; Sashidhar R Yerram; Kalpesh Patel; Nilofer S Azad; James G Herman; Scott E Kern
Journal:  Oncotarget       Date:  2013-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.